A Phase 3 interventional study of Behavior Therapy in Behavior Therapy, sponsored by University of Washington. Completed at 14 sites in United States. Open to male participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2017-01-12.
Sponsored by University of Washington · Phase 3, Interventional, and Treatment
The purpose of this study is to evaluate a five-session Human Immunodeficiency Virus/Acquired Immune Deficiency Disease (HIV/AIDS) group therapy designed specifically for heterosexual men. This therapy is compared to standard HIV/AIDS education, which generally consists of a single session of HIV education.
University of Washington is the lead sponsor of 1,431 studies on the registry; 226 are open to participants now.
Of its 158 completed or terminated interventional studies of FDA-regulated products, 136 (86%) have results posted.
Counted across the registry records on this site, refreshed daily.
All adult males age 18 and above in drug abuse treatment at participating Community Treatment Providers will be invited to participate.
AIDS risk behavior
This study is completed, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.